Iya Kessler
General Counsel & Corporate Secretary Arbor Biotechnologies, Inc.
Seminars
Thursday 6th August 2026
Panel Discussion: Practical Considerations in Cross-Border Transactions Amid Geopolitical & Market Uncertainty
2:10 pm
- Evaluate how public policy shifts, geopolitical uncertainty, and changes across the international biopharma landscape are reshaping transaction structures, negotiations, and deal execution
- Future-proof cross-border transactions by building flexibility into deal terms, governance frameworks, and risk allocation mechanisms amid continued market uncertainty
- Strengthen diligence and decision-making when evaluating international assets, partners, and opportunities while preparing for emerging trends in cross-border dealmaking
Wednesday 5th August 2026
Fireside Chat: Structuring Biotech Collaborations for Value, Control & Longevity
4:30 pm
- Current negotiation trends in licensing and collaboration deals with big pharma and peer biotechs in competitive global markets
- Strategies for protecting platform IP and downstream inventions in collaborations
- Governance frameworks supporting long‑term alliances to maximize control and maintain strategic focus
Thursday 6th August 2026
Fireside Chat: Developing the Next Generation of GC Leadership to Strengthen Succession & Enterprise Resilience
4:25 pm
- Build internal talent pipelines by intentionally developing senior counsel for broader enterprise leadership
- Equip high-performing in-house lawyers with the judgment, cross-functional fluency, and board exposure required for GC readiness
- Strengthen organizational stability through deliberate succession planning and leadership mentoring
